FBIO
NASDAQ
US
Fortress Biotech, Inc. - Common Stock
$2.60
▲ +$0.13
(+5.26%)
Vol 517K
5
Quality Score
fail
Rev ✗
NI ✗
>IPO ✗
Mkt Cap
$113.6M
P/E
28.5
ROE
11.0%
Margin
6.4%
D/E
95.59
Beta
1.46
52W
$1–$4
Wall Street Consensus
8 analysts · Apr 20262
Strong Buy
5
Buy
1
Hold
0
Sell
0
Strong Sell
87.5%
Buy Rating
Price Chart
Similar Stocks
MCRB
Seres Therapeutics Inc
P/E 25.0
$134.6M
GOSS
Gossamer Bio Inc
$717.5M
HURA
TuHURA Biosciences Inc
$45.9M
ANIX
Anixa Biosciences Inc
$102.7M
ATYR
aTyr Pharma Inc
$76.7M
GANX
Gain Therapeutics Inc
$123.8M
INO
Inovio Pharmaceuticals Inc
$119.5M
SERA
Sera Prognostics Inc
$113.9M
COEP
Coeptis Therapeutics Holdings Inc
$76.1M
Earnings
Beat rate: 60.0%
Next Report
May 13, 2026
| Quarter | EPS Est | EPS Act | Surprise |
|---|---|---|---|
| Mar 2026 | — | — | — |
| Dec 2025 | $0.11 | $-0.01 | $-0.12 |
| Sep 2025 | $-0.43 | $0.11 | +$0.54 |
| Jun 2025 | $-0.37 | $-0.50 | $-0.13 |
Fundamentals Trend
| Metric | 2025-06-30 | 2025-09-02 | 2025-10-02 | 2025-11-03 | 2025-12-03 | 2026-01-02 |
|---|---|---|---|---|---|---|
| ROE (TTM) | -53.5% | -196.0% | -53.5% | -53.5% | -53.5% | 11.0% |
| P/E (TTM) | — | — | — | — | — | 28.49 |
| Net Margin | 94.3% | -71.2% | -24.8% | -24.8% | -24.8% | 6.4% |
| Gross Margin | 69.9% | 67.4% | 70.9% | 70.9% | 70.9% | 71.6% |
| D/E Ratio | 122.43 | 261.83 | 122.43 | 122.43 | 122.43 | 95.59 |
| Current Ratio | 1.92 | 1.72 | 1.92 | 1.92 | 1.92 | 2.19 |
Key Ratios
ROA (TTM)
2.4%
P/S (TTM)
1.82
P/B
2.5
EPS (TTM)
$0.04
CF/Share
$-25.80
Rev Growth 3Y
-5.7%
52W High
$4.20
52W Low
$1.33
$1.33
52-Week Range
$4.20
How does FBIO compare to Biotechnology peers?
Peer group: Micro-cap Biotechnology (All) · 528 companies
FBIO valuation vs Biotechnology peers
P/E ratio
28.5
▲
52%
above
peers
(18.8)
vs Peers
vs Industry
Undervalued
P/S ratio
1.8
▼
86%
below
peers
(12.9)
vs Peers
vs Industry
Undervalued
P/B ratio
2.5
▼
0%
below
peers
(2.5)
vs Peers
vs Industry
Fair value
Div yield
—
▼
0%
below
peers
(0.0%)
vs Peers
vs Industry
Low yield
FBIO profitability vs Biotechnology peers
ROE
11.0%
▲
116%
above
peers
(-67.3%)
vs Peers
vs Industry
Top tier
Net margin
6.4%
▲
102%
above
peers
(-286.8%)
vs Peers
vs Industry
Below avg
Gross margin
71.6%
▼
9%
below
peers
(78.6%)
vs Peers
vs Industry
Weak
ROA
2.4%
▲
105%
above
peers
(-46.7%)
vs Peers
vs Industry
Top tier
FBIO financial health vs Biotechnology peers
D/E ratio
95.6
▼
0%
below
peers
(0.0)
vs Peers
vs Industry
High debt
Current ratio
2.2
▼
51%
below
peers
(4.4)
vs Peers
vs Industry
Low liquidity
Beta
1.5
▲
51%
above
peers
(1.0)
vs Peers
vs Industry
More volatile
FBIO fundamentals radar
FBIO
Peer median
Industry
FBIO profitability vs leverage
Bubble size = market cap · X = net margin · Y = D/E ratio
FBIO vs peers: key metrics
Latest News
No related news yet